SYNOPSIS In two families with severe sex-linked muscular dystrophy, high levels of ct-hydroxybutyrate dehydrogenase (HBD), lactate dehydrogenase (LD), aspartate transaminase (AspT), aldolase, and creatine phosphokinase (CPK) were found in the sera of three young affected males. In both families the mother had a raised level of HBD activity. Four sisters of the three affected boys had raised serum enzyme levels, and they are regarded as presumptive carriers of the disease. Biopsy specimens of dystrophic muscle had LD and HBD contents which were significantly lower than those of control specimens, while the HBD/LD ratios were markedly greater. Muscle from two unaffected members of the same family also exhibited high ratios, indicating the presence of the electrophoretically fast LD isoenzymes, and this was confirmed by acrylamide-gel electrophoresis.
All the affected individuals had a history of pseudohypertrophy of the calves with initial onset of the condition in the muscles of the pelvic girdle and spread to those of the shoulder girdle. In family A ( Fig. 1 (Dawson, Goodfriend, and Kaplan, 1964; Brody, 1964; Rosalki, 1964) . In red muscle, e.g., soleus, most of the enzyme occurs in the fast fractions LD1 and LD2, whereas in white muscle, e.g., gastrocnemius, the slow fractions are the characteristic forms. Two specimens of triceps muscle, taken at necropsy, were used as controls and these were supplemented by seven biopsy specimens of latissimus dorsi taken from patients undergoing thoracic surgery. In none of these cases was there a history of cardiac, hepatic, haematological, or muscular disease.
Blood was collected by venepuncture into plain glass bottles. The serum, which was separated within an hour, was stored frozen at -18°C. during transit and until enzyme activity was determined.
DETERMINATION OF ENZYME ACTIVITY The activities of SLD and SHBD were determined spectrophotometrically at 25°C. by the methods of Wr6blewski and LaDue (1955) and Rosalki and Wilkinson (1960) respectively. Muscle extract, diluted with 0-067M-S0rensen phosphate buffer (pH 7 4) (0-1 ml.), was mixed with phosphate buffer (2-7 ml.), reduced NAD (0-25 mg. in 0 1 ml. phosphate buffer) was added, and the resultant mixture was allowed to equilibrate at 25°C. for 30 minutes. The substrate (0 022N-sodium pyruvate or 0-1 M-sodium ox-oxobutyrate, both at pH 7-4 in phosphate buffer) (0 1 ml.) was then added and the extinction at 340 myz was measured at 25°C. Activities are expressed as micromoles of NADH2 oxidized per minute (i.u.).
Aspartate aminotransferase activity was determined by the method of Karmen (1955) Creatine phosphokinase activity was determined by the colorimetric method of Dreyfus and Schapira (1961) and results are expressed as micromoles of creatine liberated from creatine phosphate per minute (i.u.).
Acrylamide gel electrophoresis The method of Raymond and Weintraub (1959) was used in conjunction with the vertical electrophoresis apparatus2 of Raymond (1962) .
009M-Tris buffer ofpH 9-2 was prepared by dissolving 2-amino-2-(hydroxymethyl)-1,3-propanediol (10-8 g.), ethylenediamine-tetra-acetic acid (0 93 g.), and boric acid (0-43 g.) in deionized water and adjusting the volume to I litre.
Dimethylaminopropionitrile (300 mg.) was added to 150 ml. of a 5% w/v solution of Cyanogum 41 (acrylamide containing 5% methylene-bis-acrylamide)3 in 009M-tris buffer (pH 9 2). Ammonium persulphate (300 mg.) dissolved in 2 ml. tris buffer was added and the resulting solution was transferred without delay to the electrophoresis apparatus where it was allowed to gel. After about 30 minutes, the apparatus was filled with tris buffer, and water at 0 to 5°C. was Specimens (200 mg.) were washed free from blood with 0-9% NaCl and were then homogenized at 0°C. with 0 067M-S0rensen phosphate buffer at pH 7-4 (0-6 ml.) in a Potter-Elvehjem homogenizer with a Teflon pestle. The extracts were centrifuged at 3,000 g at 4°C. for 10 min. and the supernatant fractions were separated. Electrophoresis and enzyme assays were carried out on freshly prepared extracts. For enzyme determination, samples were suitably diluted (usually tenfold) with phosphate buffer. Table I shows the HBD and LD enzyme levels in the four extracts of muscle from the available relatives in family A and in the control muscles. In all three brothers the LD activities were lower than in any one of the control series, and in the two affected members the difference was marked, but the enzyme levels for the mother were apparently normal. However, the four members of the family, especially the affected boys, had muscle HBD/LD ratios that were very much higher than any of the control values. Figure 3 illustrates the LD isoenzyme pattern obtained by acrylamide gel electrophoresis of the extracts of normal (white) muscle, dystrophic muscle, and muscle of the mother, a presumptive carrier. In both affected children most activity was observed in the fastest bands LD1, LD2, and LD3, whereas LD4 was faint and LD5 was not detectable. The patterns for the mother and the unaffected brother revealed larger proportions of the slow bands but in both cases LD1, LD2, and LD3 predominated, while in normal muscle LD3, LD4, and LD5 were the principal components. Figure 4 shows the effect of replacing lactate by between the activities in muscle and sera; whereas the activities in muscle specimens from the dystrophic patients are much lower than those of the controls, the values for the corresponding sera were appreciably greater than the control figures. Table II shows the serum levels of LD, HBD, AspT, AlT, aldolase, and creatine phosphokinase of the available members in both families. There was a high overall incidence of abnormal levels of dehydrogenase activity, the highest occurring in the dys- In neither family did the HBD/LD ratio for the serum distinguish between the affected males, their unaffected relatives, and normal controls.
RESULTS

DISCUSSION
In these familial studies, the degree of LD and HBD enzyme activity found in the muscle of the different members cannot be reconciled with a simple sex-linked mode of inheritance, ncr do the results for sera reflect the enzyme activity in muscle.
The LD activity of the extracts from the dystrophic muscle, expressed per milligram of soluble protein, were only 6 to 62 % of the corresponding values for the controls. It was also marginally lowered in the extract from the unaffected male sib, but appeared to be normal in the maternal specimen. In all four muscle extracts, however, the HBD/LD ratios were markedly greater than those for the controls, and the highest values were obtained with the dystrophic muscles. The ratios for the mother and unaffected male sib were intermediate between those for the affected sibs and the controls. These findings suggest the presence of a biochemical abnormality in the muscle of the unaffected individuals in whom no clinical signs of the disease can be found. An increase in the HBD/LD ratio has been shown to indicate a preponderance of the fast migrating isoenzymes LD1 and LD2 (Rosalki and Wilkinson, 1960; Plummer et al., 1963 ), and we have been able to demonstrate by electrophoresis increases in those isoenzymes relative to normal muscle. This confirms the earlier electrophoretic studies of dystrophic muscle Wieme and Herpol, 1962; Dreyfus et al., 1962) .
In the present work, the increased HBD/LD ratio in muscle clearly identifies the affected boys and the 'carrier female', but such interpretations are made with caution in view of the abnormal value shown by the unaffected male sib. The result in the unaffected boy was confirmed by independent determinations in London and in Philadelphia, but at present we cannot offer an explanation. A difference in the HBD/LD ratios of the order observed, however, is unlikely to be due to errors arising during enzyme determination, since the precision of the latter is within ± 5 %.
Determination of muscle enzyme activities in dystrophic muscle has recently been criticized because proliferation of connective tissue might lead to errors. In this work the muscle extracts were centrifuged to remove insoluble matter and the enzyme activities related to the soluble protein content. The results would be invalid only in the unlikely event of a compensating increase in the soluble protein content of muscle.
Several workers (Schapira et al., 1953; Dreyfus et al., 1958; Vignos and Lefkowitz, 1959; Pennington, 1962) have reported that dystrophic muscle has lower activities of the glycolytic enzymes, aldolase and phosphorylase, and of creatine phosphokinase and adenylate kinase than normal muscle. Our finding of reduced LD activity is consistent with that of Heyck, Laudahn, and Luders (1963) but conflicts with that of Ronzoni, Berg, and Landau (1960) who found the LD level to be increased though the aldolase and creatine phosphokinase levels were reduced. This difference may in part be due to the duration of the illness and the gross wasting of the musculature in both patients whom we studied. However, the low figures found in their asymptomatic brother and mother cannot be attributed to such a cause.
A decrease in the LD5 content of muscle has been reported after experimental nerve section (Wieme and Lauryssens, 1962; Dawson et al., 1964; Lauryssens, Lauryssens, and Zondag, 1964) and Brody (1965) has recently shown that in guinea-pig red muscle there is loss of LD1. It may therefore be that changes in the LD isoenzyme content in human progressive muscular dystrophy are not specific for the dystrophic process, but are the consequence of changes in membrane permeability resulting in the disproportionate loss of the slow isoenzymes.
Whatever may be the mechanism involved, there is no doubt that the LD of dystrophic muscle, as shown during this investigation, is different from that of comparable normal white muscle. Since LD1 and LD2 are sensitive to inhibition by excess pyruvate, they are not capable of sustaining prolonged anaerobic glycolysis (Plagemann, Gregory, and Wroblewski, 1960; Cahn, Kaplan, Levine, and Zwilling, 1962) . Such isoenzymes occur in heart muscle which functions in an aerobic environment, while normal white muscle isoenzymes LD4 and LD5 can continue to convert pyruvate into lactate in the presence of excess substrate. The predominance of LD1 and LD2 in dystrophic muscle may partly explain the three-fold decline in glycolytic activity as compared with normal muscle (Dreyfus et al., 1958) .
In both families the serum enzyme levels for the dystrophic boys were grossly elevated, but of equal importance were the elevated levels in the unaffected females, all of whom are genetically 'at risk' as carriers of the harmful trait. The enzyme activities of the unaffected male sibs of the propositi in both families were within the normal range.
The serum aldolase has not proved to be very satisfactory for detection of the carrier state (Leyburn, Thomson, and Walton, 1961; Clayton, Wilson, and Carter, 1963) and determination of creatine phosphokinase has been recommended as the most helpful biochemical test for this purpose (Aebi, Richterich, Colombo, and Rossi, 1961; Hughes, 1962; Wilson, Evans, and Carter, 1965 An interesting finding in family A is the high creatine phosphokinase activity observed on several occasions in the serum of the father (II1), which has no apparent clinical explanation. As he was unemployed at the time, his raised levels cannot be attributed to strenuous muscular work. Such values are more likely to be found in a heterozygote carrier of the trait, but there is no evidence for any mode of inheritance other than sex-linked.
In family B, with known sex-linked inheritance, all the serum enzymes of the affected boy have high levels of activity. The increased serum HBD, AspT, and creatine phosphokinase activities shown by the eldest half-sister (III1) is again a grave prognosis for the 'carrier state', but the youngest sister (1117), in whom normal serum enzyme activities were observed, is not likely to be a carrier of the harmful gene. There is a very marked difference between the high serum HBD and creatine phosphokinase level for the carrier mother (112) and the normal level of her sister (115) who has an unaffected son.
In neither family was there an increase in the SHBD/SLD ratio above the upper normal limit (0-81), nor was there any significant difference between these ratios in the affected, the unaffected, and the control series. This is contrary to previous findings of high ratios ; the difference may be due to the greater degree of genetic and clinical homogeneity of the present data.
Although the serum LD and HBD activities are not specific for identifying carrier females they do provide a useful adjunct to the evidence provided by the serum creatine phosphokinase level in these women. Schapira and Demos (1962) have reported a slight but significant increase in the maternal serum LD levels of 27 patients with dystrophy; the present work suggests that measurement of the serum HBD activity would give a more pronounced increase that might possibly be of greater diagnostic value than the LD determination. No single biochemical test has a high degree of accuracy when used for this purpose and it would appear that all the relevant enzyme assays are required to assess the potential carrier genotype of those girls in families with sexlinked muscular dystrophy.
